Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Pyloromyotomy | Review

A global bibliometric and visualized analysis of the status and trends of gastroparesis research

Authors: Meng Li, Ning Gao, Shaoli Wang, Yufeng Guo, Zhen Liu

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Gastroparesis has a substantial impact on the quality of life but has limited treatment options, which makes it a public health concern. No bibliometric studies on gastroparesis have been published thus far. Thus, this article aims to summarize and analyze research hotspots to provide a reference for clinical researchers.

Materials and methods

Gastroparesis-related research articles were searched in the Web of Science Core Collection (WOSCC), and relevant information was extracted after screening. A total of 1033 documents were analyzed with the bibliometric method using Microsoft Excel, Citespace, and VOSviewer.

Results

Overall, our search retrieved 1033 papers contributed by 966 research institutions from 53 countries. Since 1980, publications in this field have increased rapidly. United States (n = 645) and Temple University (n = 122) were the most productive country and institution, respectively. Parkman, with 96 publications, was the most prominent author.

Conclusions

Research hotspots in gastroparesis can be summarized into four domains: innovation in diagnostic modalities, change of oral therapeutic agents, choice of surgical interventions, and pathological mechanisms. Future research on gastroparesis should focus on the quality of life of patients, diagnostic techniques, pyloromyotomy, and transpyloric stent placement.
Literature
1.
Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011;9(1):5-e7.CrossRefPubMed
2.
Huang IH, Schol J, Khatun R, Carbone F, Van den Houte K, Colomier E, et al. Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the united European gastroenterology (UEG) and European society for neurogastroenterology and motility (ESNM) consensus on gastroparesis. United Eur Gastroenterol J. 2022;10(8):888–97.CrossRef
3.
Kim KH, Lee MS, Choi TY, Kim TH. Acupuncture for symptomatic gastroparesis. Cochrane Database Syst Rev. 2018;12(12): CD009676.PubMed
4.
Ye Y, Jiang B, Manne S, Moses PL, Almansa C, Bennett D, et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. 2021;70(4):644–53.CrossRefPubMed
5.
Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–33.CrossRefPubMed
6.
Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd. Prevalence of hidden gastroparesis in the community: the gastroparesis “iceberg.” J Neurogastroenterol Motil. 2012;18:34–42.PubMedCentralCrossRefPubMed
7.
Kim BJ, Kuo B. Gastroparesis and functional dyspepsia: a blurring distinction of pathophysiology and treatment. J Neurogastroenterol Motil. 2019;25(1):27–35.PubMedCentralCrossRefPubMed
8.
9.
Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140(1):101–15.CrossRefPubMed
10.
Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43(11):2398–404.CrossRefPubMed
11.
Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012;107(1):82–8.CrossRefPubMed
12.
Cipriani G, Gibbons SJ, Miller KE, Yang DS, Terhaar ML, Eisenman ST, et al. Change in populations of macrophages promotes development of delayed gastric emptying in mice. Gastroenterology. 2018;154(8):2122-2136.e12.CrossRefPubMed
13.
Lacy BE, Crowell MD, Mathis C, Bauer D, Heinberg LJ. Gastroparesis: quality of life and health care utilization. J Clin Gastroenterol. 2018;52(1):20–4.CrossRefPubMed
14.
Chen C. Science mapping: a systematic review of the literature. J Inf Sci. 2017;2:1–40.
15.
Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38.CrossRefPubMed
16.
Aghaei Chadegani A, Salehi H, Yunus MM, Farhadi H, Fooladi M, Farhadi M, et al. A Comparison between two main academic literature collections: Web of Science and Scopus databases. Asian Soc Sci. 2013;9(5):18–26.
17.
Feng XW, Hadizadeh M, Zheng LH, Li WH. A bibliometric and visual analysis of exercise intervention publications for Alzheimer’s disease (1998–2021). J Clin Med. 2022;11(19):5903.PubMedCentralCrossRefPubMed
18.
Ma S, Guo X, Wang C, Yin Y, Xu G, Chen H, et al. Association of Barrett’s esophagus with Helicobacter pylori infection: a meta-analysis. Ther Adv Chronic Dis. 2022;13:20406223221117972.PubMedCentralCrossRefPubMed
19.
Eusebi LH, Telese A, Cirota GG, Haidry R, Zagari RM, Bazzoli F, et al. Effect of gastro-esophageal reflux symptoms on the risk of Barrett’s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(8):1507–16.PubMedCentralCrossRefPubMed
20.
Memon AR, Vandelanotte C, Olds T, Duncan MJ, Vincent GE. Research combining physical activity and sleep: a bibliometric analysis. Percept Mot Skills. 2020;127(1):154–81.CrossRefPubMed
21.
Zyoud SH, Shakhshir M, Koni A, Abushanab AS, Shahwan M, Jairoun AA, et al. Mapping the global research landscape on insulin resistance: visualization and bibliometric analysis. World J Diabetes. 2022;13(9):786–98.PubMedCentralCrossRefPubMed
22.
Chen JW, Guan Y, Zheng YL, Zhu K. Research trends and frontiers in exercise for movement disorders: a bibliometric analysis of global research from 2010 to 2021. Front Aging Neurosci. 2022;14: 977100.PubMedCentralCrossRefPubMed
23.
24.
Zhang N, Li C, Chen J, Liu X, Wang Z, Ni J. Research hotspots and frontiers about role of visual perception in stroke: a bibliometric study. Front Neurol. 2022;13: 958875.PubMedCentralCrossRefPubMed
25.
Li J, Chen C. Citespace: scientific text mining and visualization. China: Capital University of Economics and Business Press; Beijing; 2016. p. 117–9.
26.
Shi Y, Wei W, Li L, Wei Q, Jiang F, Xia G, et al. The global status of research in breast cancer liver metastasis: a bibliometric and visualized analysis. Bioengineered. 2021;12(2):12246–62.PubMedCentralCrossRefPubMed
27.
Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;48(4):797–812.CrossRefPubMed
28.
Parkman HP, Van Natta ML, Abell TL, McCallum RW, Sarosiek I, Nguyen L, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013;310(24):2640–9.PubMedCentralCrossRefPubMed
29.
Pasricha PJ, Yates KP, Sarosiek I, McCallum RW, Abell TL, Koch KL, et al. Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders. Gastroenterology. 2018;154(1):65-76.e11.CrossRefPubMed
30.
Hasler WL, Parkman HP, Wilson LA, Pasricha PJ, Koch KL, Abell TL, et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010;105(11):2357–67.PubMedCentralCrossRefPubMed
31.
Parkman HP, Wilson LA, Farrugia G, Koch KL, Hasler WL, Nguyen LA, et al. Delayed gastric emptying associates with diabetic complications in diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 2019;114(11):1778–94.PubMedCentralCrossRefPubMed
32.
Wu H, Cheng K, Guo Q, Yang W, Tong L, Wang Y, et al. Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: a bibliometric analysis. Front Med (Lausanne). 2021;23(8): 787228.CrossRef
33.
Yu X, Yu C, He W. Emerging trends and hot spots of NLRP3 inflammasome in neurological diseases: a bibliometric analysis. Front Pharmacol. 2022;13: 952211.PubMedCentralCrossRefPubMed
34.
Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322(15):1028–31.CrossRefPubMed
35.
Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136(4):1225–33.CrossRefPubMed
36.
Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125(2):421–8.CrossRefPubMed
37.
McCallum RW, Chen JD, Lin Z, Schirmer BD, Williams RD, Ross RA. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114(3):456–61.CrossRefPubMed
38.
Gao M, Zhang H, Gao Z, Sun Y, Wang J, Wei F, et al. Global hotspots and prospects of perimenopausal depression: a bibliometric analysis via CiteSpace. Front Psychiatry. 2022;13: 968629.PubMedCentralCrossRefPubMed
39.
Long D, Mao C, Zhang X, Liu Y, Shangguan X, Zou M, et al. Coronary heart disease and gut microbiota: a bibliometric and visual analysis from 2002 to 2022. Front Cardiovasc Med. 2022;9: 949859.PubMedCentralCrossRefPubMed
40.
Sachdeva P, Kantor S, Knight LC, Maurer AH, Fisher RS, Parkman HP. Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy. Dig Dis Sci. 2013;58(7):2001–6.CrossRefPubMed
41.
Pasricha PJ, Camilleri M, Hasler WL, Parkman HP. White paper AGA: gastroparesis: clinical and regulatory insights for clinical trials. Clin Gastroenterol Hepatol. 2017;15(8):1184–90.PubMedCentralCrossRefPubMed
42.
Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index. Aliment Pharmacol Ther. 2003;18(1):141–50.CrossRefPubMed
43.
Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011;8(8):438–53.CrossRefPubMed
44.
Radetic M, Kamal A, Rouphael C, Kou L, Lyu R, Cline M. Severe gastroparesis is associated with an increased incidence of slow-transit constipation as measured by wireless motility capsule. Neurogastroenterol Motil. 2021;33(5): e14045.CrossRefPubMed
45.
Griffith GH, Owen GM, Kirkman S, Shields R. Measurement of rate of gastric emptying using chromium-51. Lancet. 1966;1(7449):1244–5.CrossRefPubMed
46.
Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology. 1998;115(3):747–62.CrossRefPubMed
47.
Donohoe KJ, Maurer AH, Ziessman HA, Urbain JL, Royal HD, Martin-Comin J, et al. Procedure guideline for adult solid-meal gastric-emptying study 3.0. J Nucl Med Technol. 2009;37(3):196–200.CrossRefPubMed
48.
Parkman HP. Scintigraphy for evaluation of patients for GI motility disorders—the referring physician’s perspective. Semin Nucl Med. 2012;42(2):76–8.CrossRefPubMed
49.
Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753–63.CrossRefPubMed
50.
Wise JL, Vazquez-Roque MI, McKinney CJ, Zickella MA, Crowell MD, Lacy BE. Gastric emptying scans: poor adherence to national guidelines. Dig Dis Sci. 2021;66(9):2897–906.CrossRefPubMed
51.
Camilleri M, Shin A. Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis. Dig Dis Sci. 2013;58(7):1813–5.CrossRefPubMed
52.
Ziessman HA, Chander A, Clarke JO, Ramos A, Wahl RL. The added diagnostic value of liquid gastric emptying compared with solid emptying alone. J Nucl Med. 2009;50(5):726–31.CrossRefPubMed
53.
54.
55.
Usai-Satta P, Bellini M, Morelli O, Geri F, Lai M, Bassotti G. Gastroparesis: new insights into an old disease. World J Gastroenterol. 2020;26(19):2333–48.PubMedCentralCrossRefPubMed
56.
Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008;6(6):635-643.e1.PubMedCentralCrossRefPubMed
57.
Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993;104(6):1640–7.CrossRefPubMed
58.
Grover M, Farrugia G, Stanghellini V. Gastroparesis: a turning point in understanding and treatment. Gut. 2019;68(12):2238–50.CrossRefPubMed
59.
George NS, Sankineni A, Parkman HP. Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci. 2014;59(3):645–52.CrossRefPubMed
60.
Tran K, Brun R, Kuo B. Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice. Ther Adv Gastroenterol. 2012;5(4):249–60.CrossRef
61.
Sangnes DA, Søfteland E, Bekkelund M, Frey J, Biermann M, Gilja OH, et al. Wireless motility capsule compared with scintigraphy in the assessment of diabetic gastroparesis. Neurogastroenterol Motil. 2020;32(4): e13771.CrossRefPubMed
62.
Lee AA, Rao S, Nguyen LA, Moshiree B, Sarosiek I, Schulman MI, et al. Validation of diagnostic and performance characteristics of the wireless motility capsule in patients with suspected gastroparesis. Clin Gastroenterol Hepatol. 2019;17(9):1770-1779.e2.CrossRefPubMed
63.
Ingrosso MR, Camilleri M, Tack J, Ianiro G, Black CJ, Ford AC. Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis. Gastroenterology. 2023;164(4):642–54.CrossRefPubMed
64.
Camilleri M. Beyond metoclopramide for gastroparesis. Clin Gastroenterol Hepatol. 2022;20(1):19–24.CrossRefPubMed
65.
Hejazi RA, McCallum RW. Diabetic gastroparesis: a review of medical treatments. Prac Gastroenterol. 2009;24:10–20.
66.
Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol Motil. 2014;26(4):521–8.CrossRefPubMed
67.
McCallum RW, Ricci DA, Rakatansky H, Behar J, Rhodes JB, Salen G, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6(5):463–7.CrossRefPubMed
68.
Ricci DA, Saltzman MB, Meyer C, Callachan C, McCallum RW. Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol. 1985;7(1):25–32.CrossRefPubMed
69.
Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray reduces symptoms of gastroparesis in women, but not men, with diabetes: results of a phase 2B randomized study. Clin Gastroenterol Hepatol. 2015;13(7):1256-1263.e1.CrossRefPubMed
70.
Lai CH, Yeh YC, Chen YY. Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of parkinsonism. Ther Adv Drug Saf. 2019;10:2042098619854007.PubMedCentralCrossRefPubMed
71.
American Diabetes Association. 7. Approaches to glycemic treatment. Diabetes Care. 2016;39(Suppl 1):S52–9.CrossRef
72.
73.
Mansi C, Savarino V, Vigneri S, Perilli D, Melga P, Sciabà L, et al. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol. 1995;90(11):1989–93.PubMed
74.
Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2010;19(6):765–75.CrossRefPubMed
75.
De Maeyer JH, Lefebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil. 2008;20(2):99–112.CrossRefPubMed
76.
Cutts TF, Luo J, Starkebaum W, Rashed H, Abell TL. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005;17(1):35–43.CrossRefPubMed
77.
Andrews CN, Woo M, Buresi M, Curley M, Gupta M, Tack J, et al. Prucalopride in diabetic and connective tissue disease-related gastroparesis: randomized placebo-controlled crossover pilot trial. Neurogastroenterol Motil. 2021;33(1): e13958.CrossRefPubMed
78.
Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, et al. Prucalopride in gastroparesis: a randomized placebo-controlled crossover study. Am J Gastroenterol. 2019;114(8):1265–74.CrossRefPubMed
79.
Fahler J, Wall GC, Leman BI. Gastroparesis-associated refractory nausea treated with aprepitant. Ann Pharmacother. 2012;46(12): e38.CrossRefPubMed
80.
Chong K, Dhatariya K. A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant. Nat Rev Endocrinol. 2009;5(5):285–8.CrossRefPubMed
81.
Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, et al. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology. 2015;149(7):1762-1774.e4.CrossRefPubMed
82.
Bortolotti M. Gastric electrical stimulation for gastroparesis: a goal greatly pursued, but not yet attained. World J Gastroenterol. 2011;17(3):273–82.PubMedCentralCrossRefPubMed
83.
Saleem S, Hussain A, Alsamman MA, Inayat F, Kaler J, Tansel A, et al. Characteristics of patients who underwent gastric electrical stimulation vs surgical pyloric interventions for refractory gastroparesis. Saudi J Gastroenterol. 2021;27(5):309–15.PubMedCentralCrossRefPubMed
84.
Bilgutay AM, Wingrove R, Griffen WO, Bonnabeau RC Jr, Liliehei CW. Gastro-intestinal pacing: a new concept in the treatment of ileus. Ann Surg. 1963;158(3):338–48.PubMedCentralCrossRefPubMed
85.
Sarna SK. Gastrointestinal electrical activity: terminology. Gastroenterology. 1975;68(6):1631–5.CrossRefPubMed
86.
87.
88.
Ward MP, Gupta A, Wo JM, Rajwa B, Furness JB, Powley TL, et al. An emerging method to noninvasively measure and identify vagal response markers to enable bioelectronic control of gastroparesis symptoms with gastric electrical stimulation. J Neurosci Methods. 2020;336: 108631.PubMedCentralCrossRefPubMed
89.
Forster J, Sarosiek I, Delcore R, Lin Z, Raju GS, McCallum RW. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg. 2001;182(6):676–81.CrossRefPubMed
90.
Saleem S, Aziz M, Khan AA, Williams MJ, Mathur P, Tansel A, et al. Gastric electrical stimulation for the treatment of gastroparesis or gastroparesis-like symptoms: a systemic review and meta-analysis. Neuromodulation. 2022;S1094–7159(22):01338–41.
91.
McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I. Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol. 2011;9(4):314-319.e1.CrossRefPubMed
92.
McCallum RW, Dusing RW, Sarosiek I, Cocjin J, Forster J, Lin Z. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol Motil. 2010;22(2):161–7, e50-1.CrossRefPubMed
93.
Jayanthi NV, Dexter SP, Sarela AI; Leeds Gastroparesis Multi-Disciplinary Team. Gastric electrical stimulation for treatment of clinically severe gastroparesis. J Minim Access Surg. 2013;9(4):163–7.
94.
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.CrossRefPubMed
95.
Khashab MA, Stein E, Clarke JO, Saxena P, Kumbhari V, Chander Roland B, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2013;78(5):764–8.CrossRefPubMed
96.
Malik Z, Sankineni A, Parkman HP. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis. Neurogastroenterol Motil. 2015;27(4):524–31.CrossRefPubMed
97.
Mohan BP, Chandan S, Jha LK, Khan SR, Kotagiri R, Kassab LL, et al. Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group. Surg Endosc. 2020;34(8):3352–67.CrossRefPubMed
98.
Yan J, Tan Y, Zhou B, Zhang S, Wang X, Liu D. Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis. Rev Esp Enferm Dig. 2020;112(3):219–28.PubMed
99.
Zhang H, Zhang J, Jiang A, Ni H. Gastric peroral endoscopic myotomy for gastroparesis: a systematic review of efficacy and safety. Gastroenterol Hepatol. 2019;42(7):413–22.CrossRefPubMed
100.
Aziz M, Gangwani MK, Haghbin H, Dahiya DS, Sohail AH, Kamal F, et al. Gastric peroral endoscopic myotomy versus surgical pyloromyotomy/pyloroplasty for refractory gastroparesis: systematic review and meta-analysis. Endosc Int Open. 2023;11(4):E322–9.PubMedCentralCrossRefPubMed
101.
Montecucco C, Molgó J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005;5(3):274–9.CrossRefPubMed
102.
Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, et al. Insulin restores neuronal nitric oxide synthase expression and unction that is lost in diabetic gastropathy. J Clin Invest. 2000;106:803.PubMedCentralCrossRefPubMed
103.
Reddymasu SC, Singh S, Sankula R, Lavenbarg TA, Olyaee M, McCallum RW. Endoscopic pyloric injection of botulinum toxin-a for the treatment of postvagotomy gastroparesis. Am J Med Sci. 2009;337(3):161–4.CrossRefPubMed
104.
Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90(6):1919–25.CrossRefPubMed
105.
Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc. 2002;55(7):920–3.CrossRefPubMed
106.
Coleski R, Anderson MA, Hasler WL. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci. 2009;54(12):2634–42.CrossRefPubMed
107.
Bai Y, Xu MJ, Yang X, Xu C, Gao J, Zou DW, et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion. 2010;81(1):27–34.CrossRefPubMed
108.
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114.e3.CrossRefPubMed
Metadata
Title
A global bibliometric and visualized analysis of the status and trends of gastroparesis research
Authors
Meng Li
Ning Gao
Shaoli Wang
Yufeng Guo
Zhen Liu
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Pyloromyotomy
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01537-1

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria

Research

Functional independence, frailty and perceived quality of life in patients who developed delirium during ICU stay: a prospective cohort study

Review

The role of non-canonical Hippo pathway in regulating immune homeostasis

Research

Extracellular vesicles derived from endothelial cells modulate macrophage phenotype in vitro

Research

Altered glycosylation profiles of serum IgG in Takayasu arteritis

Review

Biofilm and wound healing: from bench to bedside